CTV outline study of pelvic lymph nodes in intensity-modulated radiotherapy for cervical cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100043240

Enrollment

Unknown

Registered

2021-02-09

Start date

2021-02-25

Completion date

Unknown

Last updated

2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer

Interventions

Observation group: patients with cervical cancer who underwent intensity-modulated radiotherapy:NA

Eligibility

Sex/Gender

Female

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with definite pathological histological diagnosis of cervical cancer. 2. with radiotherapy pointers. 3. Female patients aged 18-70 years old with KPS >= 70 points and basically normal blood routine and liver function tests. 4. Voluntarily become the subject and sign the consent form.

Exclusion criteria

Exclusion criteria: 1. Contraindicated for radiotherapy. 2. Patients with severe organ disease such as hypertension, diabetes, coronary artery disease combined before treatment. 3. Pregnancy and lactation status. 4. Patients with other malignant tumors. 5. Other conditions that are not suitable for enrollment.

Design outcomes

Primary

Measure	Time frame
Intestinal Mobility;	—

Countries

China

Contacts

Public ContactQinglian Wen

Department of Oncology, Affiliated Hospital of Southwest Medical University

wql73115@hotmail.com+86 13882713926

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026